Keywords
8-aminoquinoline , cryptic infection , glucose-6-phosphate dehydrogenase deficiency , P. vivax drug resistance , P. vivax prevention , P. vivax treatment , Plasmodium vivax , Plasmodium vivax circumsporozoite protein (PvCSP) vaccine development , radical cure